Flunixin meglumine is a potent, non-narcotic, nonsteroidal anti-inflammatory drug (NSAID) primarily used in veterinary medicine for its analgesic, anti-inflammatory, and antipyretic properties, particularly… Read more














Flunixin meglumine is a potent, non-narcotic, nonsteroidal anti-inflammatory drug (NSAID) primarily used in veterinary medicine for its analgesic, anti-inflammatory, and antipyretic properties, particularly in treating colic, musculoskeletal, and ocular pain. This category features high-quality reference standards essential for the rigorous analysis of the active pharmaceutical ingredient. Laboratories utilize these materials for impurity profiling, ensuring compliance with regulatory standards by identifying and quantifying pharmacopeial and non-pharmacopeial impurities, such as specific related compounds and degradation products. Additionally, the collection includes metabolites, such as flunixin acyl glucuronide, and stable isotope labelled compounds. These labelled internal standards are critical for precise quantification in bioanalytical methods, enabling accurate method validation and quality control throughout the pharmaceutical development and manufacturing lifecycle. Scientists rely on these comprehensive reference materials to support the safety and efficacy verification of products containing this widely used therapeutic agent.